Prognostic Value of Mannose-Binding Lectin: 90-Day Outcome in Patients with Acute Ischemic Stroke

详细信息    查看全文

• 作者：Zhi-Guo Zhang ; Chao Wang ; Jing Wang ; Zhuo Zhang ; Yan-Long Yang…
• 关键词：Mannose ; binding lectin ; Stroke ; Short term ; Prognosis
• 刊名：Molecular Neurobiology
• 出版年：2015
• 出版时间：February 2015
• 年：2015
• 卷：51
• 期：1
• 页码：230-239
• 全文大小：1,263 KB
• 参考文献：1. Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U et al (2011) Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol 10:471-80 CrossRef
  2. Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17:796-08 CrossRef
  3. Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nat Immunol 12:204-12 CrossRef
  4. Frauenknecht V, Thiel S, Storm L, Meier N, Arnold M, Schmid JP et al (2013) Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated proteinin cardio- and cerebrovascular diseases. Clin Exp Immunol 173:112-20 CrossRef
  5. Keller TT, van Leuven SI, Meuwese MC, Wareham NJ, Luben R, Stroes ES et al (2006) Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler Thromb Vasc Biol 26:2345-350 CrossRef
  6. Hansen TK, Forsblom C, Saraheimo M, Thorn L, Wadén J, H?yem P et al (2010) Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes. Diabetologia 53:1517-524 CrossRef
  7. Hovind P, Hansen TK, Tarnow L, Thiel S, Steffensen R, Flyvbjerg A et al (2005) Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study. Diabetes 54:1523-527 CrossRef
  8. Turner MW (2003) The role of mannose-binding lectin in health and disease. Mol Immunol 40:423-29 CrossRef
  9. Wang ZY, Sun ZR, Zhang LM (2014) The relationship between serum mannose-binding lectin levels and acute ischemic stroke risk. Neurochem Res 39:248-53 CrossRef
  10. Osthoff M, Katan M, Fluri F, Schuetz P, Bingisser R, Kappos L et al (2011) Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PLoS ONE 6:e21338 CrossRef
  11. Hatano S (1976) Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54:541-53
  12. Brott T, Adams HP Jr, Olinger CP et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864-70 CrossRef
  13. Adams HP, Bendixen BH, Kappelle L (1993) J, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35-1 CrossRef
  14. Bamford J, Sandercock P, Dennis M et al (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521-526 CrossRef
  15. Bonita RBR (1988) Modification of Rankin Scale: recovery of motor function after stroke. Stroke 19:1497-500 CrossRef
  16. Sims JR, Gharai L (2009) R, Schaefer, P.W, et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72:2104-110 CrossRef
  17. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect
• 刊物主题：Neurosciences; Neurobiology; Cell Biology; Neurology;
• 出版者：Springer US
• ISSN：1559-1182

文摘

Complement activation and inflammation have been suggested in the pathogenesis of stroke; mannose-binding lectin (MBL) was found to have roles during the process. We therefore evaluated the short-term prognostic value of serum MBL in Chinese patients with an acute ischemic stroke (AIS). Consecutive AIS patients admitted to the emergency department were identified. Clinical information was collected. Serum concentration of MBL and NIH Stroke Scale (NIHSS) was measured at the time of admission. Short-term functional outcome was measured by modified Rankin scale (mRS) 90?days after admission. Multivariate analyses were performed using logistic regression models. During the inclusion period, 231 patients were diagnosed with AIS, and 220 completed follow-up. The results indicated that the serum MBL levels were significantly (P--.000) higher in acutely ischemic stroke patients as compared with normal controls. MBL was an independent prognostic marker of short-term functional outcome and death (odds ratio (OR) 5.28 (2.88-0.67) and 6.99 (3.55-3.97), respectively, P--.000 for both, adjusted for NIHSS, other predictors, and vascular risk factors) in patients with AIS. MBL improved the area under the receiver operating characteristic curve of the NIHSS score for functional outcome from 0.826 (95?% CI 0.773-.879) to 0.857 (95?% CI 0.808-.905, P--.000) and for mortality from 0.768 (95?% CI 0.682-.853) to 0.822 (95?% CI 0.747-.896, P--.000). Serum MBL levels are a useful, complementary tool to predict functional outcome and mortality 90?days after stroke.